alendronate has been researched along with Adverse Effects, Long Term in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To determine the skeletal safety and efficacy of long term (≥10 years) alendronate use in patients with osteoporosis." | 3.83 | Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study. ( Abrahamsen, B; Eastell, R; Eiken, P; Prieto-Alhambra, D, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahamsen, B | 1 |
| Eiken, P | 1 |
| Prieto-Alhambra, D | 1 |
| Eastell, R | 1 |
1 other study available for alendronate and Adverse Effects, Long Term
| Article | Year |
|---|---|
Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Case-Control Studies; Cohort | 2016 |